SRF, there are two different licenses for different TB diagnostic stuff. One lot with speedx and the other to neclone. From progress updates they seem to be pushing the bayer stuff which consumed time and money as it had the best potential to provide quickest revenue streams to carry the business forward. When the bayer thing fell over, you know the rest, they looked dor deals for their ip to provide maximum benefit to share holders.
PS. Could be a twist to the bayer tsettlement none of us espect.
CGA Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held